| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.3% | 2.5% |
| Div Cover | 2.2 | 2.1 |
| Op Mrgn | 24.3% | 24.0% |
| ROCE | 56.4% |
| Latest | F'cast | |
|---|---|---|
| P/E | 20.3 | 18.9 |
| PEG | 4.0 | 2.7 |
| Pr/Revenue | 3.4 | 3.2 |
| Pr/Book | 10.3 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 2.3% | 6.6% |
| PBT | 6.6% | 6.3% |
| EPS | 5.1% | 7.1% |
| DPS | 8.2% | 8.7% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-08 | 911.10 | 96.30 | 48.00p | 10.8 | 0.2 | +62% | 19.75p | 3.8% |
| 31-Dec-09 | 827.50 | 90.80 | 53.80p | 14.9 | 1.2 | +12% | 21.50p | 2.7% |
| 31-Dec-10 | 1,001.90 | 192.30 | 95.40p | 16.9 | 0.2 | +77% | 35.00p | 2.2% |
| 31-Dec-11 | 1,028.00 | 237.50 | 122.50p | 14.7 | 0.5 | +28% | 55.00p | 3.0% |
| 31-Dec-12 | 1,051.90 | 253.20 | 128.70p | 18.5 | 3.7 | +5% | 59.50p | 2.5% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-13 | 1,120.90 | 269.24 | 137.84p | 18.9 | 2.7 | +7% | 64.70p | 2.5% |
| 31-Dec-14 | 1,187.38 | 293.66 | 150.90p | 17.3 | 1.8 | +10% | 70.72p | 2.7% |
Copyright © 2013 FactSet Research Systems Inc. All rights reserved.
| Director/PDMR Shareholding | 13-May-2013 | 16:35 | RNS |
| Director/PDMR Shareholding | 01-May-2013 | 16:30 | RNS |
| Director/PDMR Shareholding Replacement | 30-Apr-2013 | 16:42 | RNS |
| Second Croda deal for Aquapharm | 13-Jul-2011 | The Scotsman |
| No consumer slump for Croda | 29-Apr-2011 | The Independent |
| CRODA FIZZES AFTER SOLVAY DEAL | 05-Apr-2011 | Express & Star |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 10-May-13 | Transfer From | Keith Layden | 0.000p | 5 | £0.00 |
| 10-May-13 | Buy | Keith Layden | 2,473.00p | 5 | £123.65 |
| 10-May-13 | Transfer From | Sean Christie | 0.000p | 5 | £0.00 |
| Currency | UK Pounds |
| Share Price | 2,607.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 2,841.00p |
| 52 Week Low | 2,094.00p |
| Volume | 0 |
| Shares Issued | 135.78m |
| Market Cap | £3,539.83m |
| Beta | 0.82 |
| RiskGrade | 102 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 6 |
| Buy | 0 |
| Neutral | 9 |
| Sell | 0 |
| Strong Sell | 2 |
| Total | 17 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 01-May-13 | 29-Aug-12 |
| Paid | 31-May-13 | 04-Oct-12 |
| Amount | 32.75p | 26.75p |
| Finance Director | Sean Christie |
| Chair | Martin Flower |
You are here: research